For the first time, thanks to the Inflation Reduction Act, Medicare will be able to negotiate the prices of prescription drugs. The names of the first 10 drugs covered under Medicare Part D that were selected for negotiation was recently announced. The negotiations with participating drug companies will occur in 2023 and 2024, and any negotiated prices will become effective beginning in 2026.
The Inflation Reduction Act will make another key change to improve drug affordability for seniors and people with disabilities. Starting in 2024, there will be a cap on the annual out-of-pocket costs in Medicare part D. In 2025, this annual cap will be reduced to $2,000 then will be indexed annually thereafter.